A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Public ClinicalTrials.gov record NCT04539548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Parallel-Arm, Active Control, Multi-Center Study Assessing the Safety And Efficacy Of Dextenza® for the Treatment Of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Study identification
- NCT ID
- NCT04539548
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ocular Therapeutix, Inc.
- Industry
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Dextenza Ophthalmic Insert Drug
- Prednisolone acetate ophthalmic suspension USP 1% Drug
Drug
Eligibility (public fields only)
- Age range
- 0 Years to 5 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 3, 2020
- Primary completion
- Dec 20, 2023
- Completion
- Dec 20, 2023
- Last update posted
- Apr 14, 2024
2020 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ocular Therapeutix | Aurora | Colorado | 80045 | — |
| Ocular Therapeutix | Fort Collins | Colorado | 80525 | — |
| Ocular Therapeutix | Jacksonville | Florida | 32202 | — |
| Ocular Therapeutix | Indianapolis | Indiana | 46202 | — |
| Ocular Therapeutix | Lexington | Kentucky | 40508 | — |
| Ocular Therapeutix | Boston | Massachusetts | 02115 | — |
| Ocular Therapeutix | Minneapolis | Minnesota | 55454 | — |
| Ocular Therapeutix | Rochester | Minnesota | 55905 | — |
| Ocular Therapeutix | St Louis | Missouri | 63110 | — |
| Ocular Therapeutix | Erie | Pennsylvania | 16501 | — |
| Ocular Therapeutix | Charleston | South Carolina | 29425 | — |
| Ocular Therapeutix | Nashville | Tennessee | 37232 | — |
| Ocular Therapeutix | Virginia Beach | Virginia | 23452 | — |
| Ocular Therapeutix | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04539548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04539548 live on ClinicalTrials.gov.